KCNK1 and breast carcinoma: To identify potential downstream targets of KCNK1 in breast cancer, liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed after immunoprecipitation of KCNK1 in MDA-MB-231 cells (S3 Table).